Early- versus late-onset Alzheimer’s disease in clinical practice: cognitive and global outcomes over 3 years

BACKGROUND: Whether age at onset influences Alzheimer’s disease (AD) progression and the effectiveness of cholinesterase inhibitor (ChEI) therapy is not clear. We aimed to compare longitudinal cognitive and global outcomes in ChEI-treated patients with early-onset Alzheimer’s disease (EOAD) versus l...

Descripción completa

Detalles Bibliográficos
Autores principales: Wattmo, Carina, Wallin, Åsa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580278/
https://www.ncbi.nlm.nih.gov/pubmed/28859660
http://dx.doi.org/10.1186/s13195-017-0294-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580278/
https://www.ncbi.nlm.nih.gov/pubmed/28859660
http://dx.doi.org/10.1186/s13195-017-0294-2

Ejemplares similares